Mile High Labs, a Boulder, CO-based cannabinoid extractor, raised $35m in Series A financing.
Backers included institutional and private equity investors.
The company intends to use the funds to expand the production capacity of its premium Cannabidiol (CBD) extracts and grow internationally.
Led by Jason Roth, CEO, and Stephen Mueller, CTO, Mile High Labs is a concentrate manufacturer of premium CBD crude oil, distillate and isolate. The company offers extraction, refining and co-packing services to cultivators, manufacturers, retailers and companies throughout the Consumer Packaged Goods industry.
Mile High, which extracts exclusively from industrial hemp flower material, operates an end-to-end certified GMP cannabis extraction facility in the Western Hemisphere.